NorthWest Biotherapeutics Inc (NWBO)

[aboobmove]

Regarding your previous reply, I agree that the lack of info on interim efficacy analyses is weird - did they choose not to do it and "save alpha" but just never said so? Cannot imagine an independent DSMB would do an analysis then lie about it because they did not like results (thought a DSMB member said they did NOT do one). In the bigger picture beyond design and analysis details, there seems to be something accounting for unusually long survival based on blinded data to this point.

I am not sure where you got this "unusually long survival based on blinded data". There has been just dead silence and no data has been released at all. I simply don't believe anything including the meeting presentations until released by an independent DSMB (which is intended to be legally bound).